Londinia Opportunities Analyses - 09/22/2021 (GMT) NEVRO CORP. - 1H
- U.S. Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
72%
6%
22%
My opinion
Bullish above 123.46 USD
My targets
127.97 USD (+2.02%)
132.81 USD (+5.88%)
My analysis
NEVRO CORP. is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 123.46 USD. The next resistance located at 127.97 USD is the next bullish objective to be reached. A bullish break in this resistance would boost the bullish momentum. The bullish movement could then continue towards the next resistance located at 132.81 USD. After this resistance, buyers could then target 144.30 USD. With the current pattern, you will need to monitor for possible bullish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bullish trend. Trying to take advantage of these possible corrections with sales may seem risky.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
8.2
Analysis too old. There are no more charts available.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
Additional analysis
Quotes
The NEVRO CORP. price is 125.44 USD. On the day, this instrument gained +1.34% and was traded between 122.85 USD and 126.61 USD over the period. The price is currently at +2.11% from its lowest and -0.92% from its highest.122.85
126.61
125.44
The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
A technical analysis in 1H of this NEVRO CORP. chart shows a strongly bullish trend. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators market scanner is currently detecting several bullish signals that could impact this trend:
Bullish trend reversal : Moving Average 20
Type : Bullish
Timeframe : 1 hour
Bullish trend reversal : adaptative moving average 20
Type : Bullish
Timeframe : 1 hour
Moving Average bullish crossovers : MA50 & MA100
Type : Bullish
Timeframe : 1 hour
The probability of a further increase is high given the direction of the technical indicators.
But beware of excesses. The Central Indicators scanner currently detects this:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : 1 hour
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 114.16 | 117.65 | 123.46 | 125.44 | 127.97 | 132.81 | 144.30 |
| Change (%) | -8.99% | -6.21% | -1.58% | - | +2.02% | +5.88% | +15.04% |
| Change | -11.28 | -7.79 | -1.98 | - | +2.53 | +7.37 | +18.86 |
| Level | Major | Intermediate | Intermediate | - | Intermediate | Intermediate | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 119.74 | 121.58 | 122.68 | 124.52 | 125.62 | 127.46 | 128.56 |
| Camarilla | 122.97 | 123.24 | 123.51 | 123.78 | 124.05 | 124.32 | 124.59 |
| Woodie | 119.37 | 121.40 | 122.31 | 124.34 | 125.25 | 127.28 | 128.19 |
| Fibonacci | 121.58 | 122.70 | 123.40 | 124.52 | 125.64 | 126.34 | 127.46 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 109.88 | 113.76 | 120.20 | 124.08 | 130.52 | 134.40 | 140.84 |
| Camarilla | 123.79 | 124.74 | 125.68 | 126.63 | 127.58 | 128.52 | 129.47 |
| Woodie | 111.15 | 114.40 | 121.47 | 124.72 | 131.79 | 135.04 | 142.11 |
| Fibonacci | 113.76 | 117.71 | 120.14 | 124.08 | 128.03 | 130.46 | 134.40 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 38.55 | 69.05 | 95.52 | 126.02 | 152.49 | 182.99 | 209.46 |
| Camarilla | 106.33 | 111.56 | 116.78 | 122.00 | 127.22 | 132.45 | 137.67 |
| Woodie | 36.55 | 68.04 | 93.52 | 125.01 | 150.49 | 181.98 | 207.46 |
| Fibonacci | 69.05 | 90.81 | 104.25 | 126.02 | 147.78 | 161.22 | 182.99 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 58.13 | |
| MACD (12,26,9): | 0.2500 | |
| Directional Movement: | 1.28 | |
| AROON (14): | 42.86 | |
| DEMA (21): | 124.75 | |
| Parabolic SAR (0,02-0,02-0,2): | 121.72 | |
| Elder Ray (13): | 0.76 | |
| Super Trend (3,10): | 122.01 | |
| Zig ZAG (10): | 125.80 | |
| VORTEX (21): | 1.0300 | |
| Stochastique (14,3,5): | 66.96 | |
| TEMA (21): | 124.78 | |
| Williams %R (14): | -12.05 | |
| Chande Momentum Oscillator (20): | 2.32 | |
| Repulse (5,40,3): | 1.4700 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.0200 | |
| Courbe Coppock: | 1.56 |
| MA7: | 124.56 | |
| MA20: | 122.37 | |
| MA50: | 128.36 | |
| MA100: | 142.38 | |
| MAexp7: | 125.03 | |
| MAexp20: | 124.40 | |
| MAexp50: | 123.91 | |
| MAexp100: | 122.97 | |
| Price / MA7: | +0.71% | |
| Price / MA20: | +2.51% | |
| Price / MA50: | -2.27% | |
| Price / MA100: | -11.90% | |
| Price / MAexp7: | +0.33% | |
| Price / MAexp20: | +0.84% | |
| Price / MAexp50: | +1.23% | |
| Price / MAexp100: | +2.01% |
Quotes :
-
15 min delayed data
-
Actions NYSE
News
The latest news and videos published on NEVRO CORP. at the time of the analysis were as follows:
- Nevro Announces Director Appointment
- Nevro to Present at Baird 2021 Global Healthcare Conference
- Nevro to Present at Wells Fargo Virtual Healthcare Conference
- Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance
- Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)